A Study of 14C JNJ-67953964 in Healthy Adult Male Participants
NCT05197062
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
14C-aticaprant
Sponsor
Janssen Research & Development, LLC